Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
TISSUE DEVELOPMENT |
36 |
1518 |
9.881e-22 |
4.597e-18 |
2 |
ORGAN MORPHOGENESIS |
28 |
841 |
2.446e-20 |
5.69e-17 |
3 |
EMBRYO DEVELOPMENT |
28 |
894 |
1.237e-19 |
1.919e-16 |
4 |
EMBRYONIC MORPHOGENESIS |
23 |
539 |
5.735e-19 |
6.672e-16 |
5 |
PATTERN SPECIFICATION PROCESS |
21 |
418 |
9.323e-19 |
8.676e-16 |
6 |
EPITHELIUM DEVELOPMENT |
27 |
945 |
6.921e-18 |
5.367e-15 |
7 |
REGIONALIZATION |
17 |
311 |
7.362e-16 |
4.894e-13 |
8 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
32 |
1784 |
1.632e-15 |
9.494e-13 |
9 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
23 |
788 |
2.271e-15 |
1.057e-12 |
10 |
CIRCULATORY SYSTEM DEVELOPMENT |
23 |
788 |
2.271e-15 |
1.057e-12 |
11 |
HEART DEVELOPMENT |
19 |
466 |
2.504e-15 |
1.059e-12 |
12 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
14 |
207 |
1.833e-14 |
7.109e-12 |
13 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
21 |
689 |
2.098e-14 |
7.51e-12 |
14 |
GLAND DEVELOPMENT |
17 |
395 |
3.782e-14 |
1.257e-11 |
15 |
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
13 |
190 |
1.475e-13 |
4.576e-11 |
16 |
ANTERIOR POSTERIOR PATTERN SPECIFICATION |
13 |
194 |
1.93e-13 |
5.612e-11 |
17 |
SKELETAL SYSTEM DEVELOPMENT |
17 |
455 |
3.742e-13 |
1.024e-10 |
18 |
POSITIVE REGULATION OF GENE EXPRESSION |
28 |
1733 |
2.556e-12 |
6.606e-10 |
19 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
22 |
1004 |
3.378e-12 |
8.272e-10 |
20 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
28 |
1805 |
6.824e-12 |
1.588e-09 |
21 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
27 |
1672 |
7.468e-12 |
1.655e-09 |
22 |
RESPONSE TO GROWTH FACTOR |
16 |
475 |
9.678e-12 |
1.958e-09 |
23 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
19 |
740 |
9.277e-12 |
1.958e-09 |
24 |
EMBRYONIC ORGAN DEVELOPMENT |
15 |
406 |
1.276e-11 |
2.474e-09 |
25 |
NEGATIVE REGULATION OF GENE EXPRESSION |
25 |
1493 |
2.722e-11 |
4.787e-09 |
26 |
REGULATION OF CELL DIFFERENTIATION |
25 |
1492 |
2.683e-11 |
4.787e-09 |
27 |
CELL FATE COMMITMENT |
12 |
227 |
2.881e-11 |
4.787e-09 |
28 |
REGULATION OF CELL PROLIFERATION |
25 |
1496 |
2.843e-11 |
4.787e-09 |
29 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
17 |
602 |
3.184e-11 |
5.108e-09 |
30 |
TISSUE MORPHOGENESIS |
16 |
533 |
5.38e-11 |
8.344e-09 |
31 |
TUBE DEVELOPMENT |
16 |
552 |
9.023e-11 |
1.312e-08 |
32 |
POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
9 |
100 |
8.876e-11 |
1.312e-08 |
33 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
16 |
554 |
9.517e-11 |
1.342e-08 |
34 |
TUBE MORPHOGENESIS |
13 |
323 |
1.205e-10 |
1.649e-08 |
35 |
ACTIVIN RECEPTOR SIGNALING PATHWAY |
6 |
22 |
1.254e-10 |
1.667e-08 |
36 |
SEX DIFFERENTIATION |
12 |
266 |
1.81e-10 |
2.339e-08 |
37 |
HEART MORPHOGENESIS |
11 |
212 |
2.513e-10 |
3.16e-08 |
38 |
EMBRYONIC ORGAN MORPHOGENESIS |
12 |
279 |
3.131e-10 |
3.759e-08 |
39 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
18 |
801 |
3.15e-10 |
3.759e-08 |
40 |
SPECIFICATION OF SYMMETRY |
9 |
117 |
3.672e-10 |
4.271e-08 |
41 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
16 |
609 |
3.806e-10 |
4.319e-08 |
42 |
MESODERM DEVELOPMENT |
9 |
118 |
3.963e-10 |
4.391e-08 |
43 |
PALATE DEVELOPMENT |
8 |
85 |
7.294e-10 |
7.893e-08 |
44 |
MORPHOGENESIS OF AN EPITHELIUM |
13 |
400 |
1.644e-09 |
1.663e-07 |
45 |
RESPONSE TO BMP |
8 |
94 |
1.644e-09 |
1.663e-07 |
46 |
CELLULAR RESPONSE TO BMP STIMULUS |
8 |
94 |
1.644e-09 |
1.663e-07 |
47 |
POSITIVE REGULATION OF CELL COMMUNICATION |
23 |
1532 |
1.845e-09 |
1.827e-07 |
48 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
20 |
1142 |
2.09e-09 |
2.026e-07 |
49 |
GROWTH |
13 |
410 |
2.215e-09 |
2.104e-07 |
50 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
18 |
957 |
5.289e-09 |
4.922e-07 |
51 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
15 |
643 |
7.29e-09 |
6.651e-07 |
52 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
22 |
1517 |
8.764e-09 |
7.842e-07 |
53 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
10 |
229 |
9.176e-09 |
7.89e-07 |
54 |
ARTERY DEVELOPMENT |
7 |
75 |
9.495e-09 |
7.89e-07 |
55 |
MAMMARY GLAND DEVELOPMENT |
8 |
117 |
9.435e-09 |
7.89e-07 |
56 |
UROGENITAL SYSTEM DEVELOPMENT |
11 |
299 |
9.334e-09 |
7.89e-07 |
57 |
EPITHELIAL CELL DIFFERENTIATION |
13 |
495 |
2.093e-08 |
1.709e-06 |
58 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
12 |
408 |
2.252e-08 |
1.807e-06 |
59 |
DEVELOPMENTAL GROWTH |
11 |
333 |
2.826e-08 |
2.229e-06 |
60 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
15 |
724 |
3.526e-08 |
2.734e-06 |
61 |
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
7 |
95 |
4.994e-08 |
3.809e-06 |
62 |
MALE SEX DIFFERENTIATION |
8 |
148 |
5.964e-08 |
4.476e-06 |
63 |
EMBRYONIC PATTERN SPECIFICATION |
6 |
58 |
6.145e-08 |
4.538e-06 |
64 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
10 |
285 |
7.26e-08 |
5.278e-06 |
65 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
17 |
1008 |
7.509e-08 |
5.375e-06 |
66 |
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS |
9 |
216 |
7.989e-08 |
5.632e-06 |
67 |
GASTRULATION |
8 |
155 |
8.537e-08 |
5.929e-06 |
68 |
EMBRYONIC HEART TUBE MORPHOGENESIS |
6 |
62 |
9.227e-08 |
6.314e-06 |
69 |
CELL PROLIFERATION |
14 |
672 |
1.007e-07 |
6.734e-06 |
70 |
REPRODUCTION |
19 |
1297 |
1.013e-07 |
6.734e-06 |
71 |
VASCULATURE DEVELOPMENT |
12 |
469 |
1.032e-07 |
6.763e-06 |
72 |
RESPONSE TO ENDOGENOUS STIMULUS |
20 |
1450 |
1.147e-07 |
7.41e-06 |
73 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
23 |
1929 |
1.396e-07 |
8.898e-06 |
74 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
8 |
167 |
1.518e-07 |
9.546e-06 |
75 |
APPENDAGE DEVELOPMENT |
8 |
169 |
1.664e-07 |
1.019e-05 |
76 |
LIMB DEVELOPMENT |
8 |
169 |
1.664e-07 |
1.019e-05 |
77 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
15 |
823 |
1.869e-07 |
1.129e-05 |
78 |
FEMALE SEX DIFFERENTIATION |
7 |
116 |
1.985e-07 |
1.184e-05 |
79 |
EMBRYONIC HEART TUBE DEVELOPMENT |
6 |
73 |
2.477e-07 |
1.459e-05 |
80 |
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT |
7 |
122 |
2.803e-07 |
1.63e-05 |
81 |
ENDOCRINE SYSTEM DEVELOPMENT |
7 |
123 |
2.964e-07 |
1.702e-05 |
82 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
19 |
1395 |
3.143e-07 |
1.784e-05 |
83 |
KIDNEY EPITHELIUM DEVELOPMENT |
7 |
125 |
3.308e-07 |
1.855e-05 |
84 |
REGULATION OF GROWTH |
13 |
633 |
3.606e-07 |
1.998e-05 |
85 |
MESENCHYME DEVELOPMENT |
8 |
190 |
4.076e-07 |
2.231e-05 |
86 |
CELL DEVELOPMENT |
19 |
1426 |
4.405e-07 |
2.384e-05 |
87 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
7 |
131 |
4.552e-07 |
2.434e-05 |
88 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
17 |
1192 |
8.049e-07 |
4.256e-05 |
89 |
CARDIAC CHAMBER DEVELOPMENT |
7 |
144 |
8.634e-07 |
4.415e-05 |
90 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
7 |
144 |
8.634e-07 |
4.415e-05 |
91 |
MESONEPHROS DEVELOPMENT |
6 |
90 |
8.634e-07 |
4.415e-05 |
92 |
IMMUNE SYSTEM DEVELOPMENT |
12 |
582 |
1.029e-06 |
5.195e-05 |
93 |
DIGESTIVE SYSTEM DEVELOPMENT |
7 |
148 |
1.038e-06 |
5.195e-05 |
94 |
POSITIVE REGULATION OF REPRODUCTIVE PROCESS |
5 |
52 |
1.196e-06 |
5.922e-05 |
95 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
21 |
1848 |
1.284e-06 |
6.29e-05 |
96 |
POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION |
4 |
23 |
1.298e-06 |
6.291e-05 |
97 |
MAMMARY GLAND EPITHELIUM DEVELOPMENT |
5 |
53 |
1.317e-06 |
6.319e-05 |
98 |
NEUROGENESIS |
18 |
1402 |
1.629e-06 |
7.733e-05 |
99 |
IN UTERO EMBRYONIC DEVELOPMENT |
9 |
311 |
1.707e-06 |
8.023e-05 |
100 |
OUTFLOW TRACT MORPHOGENESIS |
5 |
56 |
1.739e-06 |
8.091e-05 |
101 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
15 |
983 |
1.762e-06 |
8.119e-05 |
102 |
REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY |
4 |
25 |
1.844e-06 |
8.413e-05 |
103 |
POSITIVE REGULATION OF HEMOPOIESIS |
7 |
163 |
1.982e-06 |
8.954e-05 |
104 |
CARDIAC CHAMBER MORPHOGENESIS |
6 |
104 |
2.022e-06 |
9.048e-05 |
105 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
16 |
1135 |
2.108e-06 |
9.344e-05 |
106 |
REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
5 |
60 |
2.459e-06 |
0.0001079 |
107 |
EMBRYONIC DIGIT MORPHOGENESIS |
5 |
61 |
2.671e-06 |
0.0001161 |
108 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
15 |
1036 |
3.363e-06 |
0.0001436 |
109 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
15 |
1036 |
3.363e-06 |
0.0001436 |
110 |
EMBRYONIC HINDLIMB MORPHOGENESIS |
4 |
29 |
3.425e-06 |
0.0001449 |
111 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
5 |
66 |
3.956e-06 |
0.0001629 |
112 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
18 |
1492 |
3.937e-06 |
0.0001629 |
113 |
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
5 |
66 |
3.956e-06 |
0.0001629 |
114 |
ORGAN GROWTH |
5 |
68 |
4.589e-06 |
0.0001873 |
115 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
6 |
121 |
4.882e-06 |
0.0001975 |
116 |
MYELOID CELL DIFFERENTIATION |
7 |
189 |
5.282e-06 |
0.0002119 |
117 |
STEM CELL DIFFERENTIATION |
7 |
190 |
5.468e-06 |
0.0002175 |
118 |
POSITIVE REGULATION OF CELL PROLIFERATION |
13 |
814 |
5.868e-06 |
0.0002314 |
119 |
ERYTHROCYTE HOMEOSTASIS |
5 |
73 |
6.521e-06 |
0.000255 |
120 |
REGULATION OF REPRODUCTIVE PROCESS |
6 |
129 |
7.064e-06 |
0.0002739 |
121 |
SKELETAL SYSTEM MORPHOGENESIS |
7 |
201 |
7.907e-06 |
0.0003041 |
122 |
REGULATION OF ERYTHROCYTE DIFFERENTIATION |
4 |
36 |
8.335e-06 |
0.0003179 |
123 |
RENAL TUBULE DEVELOPMENT |
5 |
78 |
9.039e-06 |
0.0003419 |
124 |
HINDLIMB MORPHOGENESIS |
4 |
37 |
9.319e-06 |
0.0003497 |
125 |
POSITIVE REGULATION OF CATENIN IMPORT INTO NUCLEUS |
3 |
12 |
9.615e-06 |
0.0003579 |
126 |
SENSORY ORGAN DEVELOPMENT |
10 |
493 |
1.031e-05 |
0.0003809 |
127 |
KIDNEY MORPHOGENESIS |
5 |
82 |
1.155e-05 |
0.0004199 |
128 |
NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION |
5 |
82 |
1.155e-05 |
0.0004199 |
129 |
NEURON DIFFERENTIATION |
13 |
874 |
1.258e-05 |
0.0004536 |
130 |
MAMMARY GLAND MORPHOGENESIS |
4 |
40 |
1.279e-05 |
0.0004543 |
131 |
NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION |
4 |
40 |
1.279e-05 |
0.0004543 |
132 |
POSITIVE REGULATION OF OSSIFICATION |
5 |
84 |
1.3e-05 |
0.0004582 |
133 |
RESPONSE TO ESTROGEN |
7 |
218 |
1.341e-05 |
0.0004692 |
134 |
CARDIAC SEPTUM DEVELOPMENT |
5 |
85 |
1.377e-05 |
0.0004782 |
135 |
NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION |
4 |
41 |
1.414e-05 |
0.0004812 |
136 |
POSITIVE REGULATION OF KIDNEY DEVELOPMENT |
4 |
41 |
1.414e-05 |
0.0004812 |
137 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
9 |
404 |
1.417e-05 |
0.0004812 |
138 |
CARTILAGE DEVELOPMENT |
6 |
147 |
1.492e-05 |
0.0005029 |
139 |
MYELOID CELL HOMEOSTASIS |
5 |
88 |
1.631e-05 |
0.000546 |
140 |
REGULATION OF HEMOPOIESIS |
8 |
314 |
1.689e-05 |
0.0005615 |
141 |
CELL FATE DETERMINATION |
4 |
43 |
1.713e-05 |
0.0005654 |
142 |
AXIS SPECIFICATION |
5 |
90 |
1.82e-05 |
0.0005921 |
143 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
12 |
771 |
1.813e-05 |
0.0005921 |
144 |
ENDOCRINE PROCESS |
4 |
44 |
1.879e-05 |
0.0006073 |
145 |
GABAERGIC NEURON DIFFERENTIATION |
3 |
15 |
1.973e-05 |
0.0006332 |
146 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
16 |
1360 |
2.082e-05 |
0.0006635 |
147 |
NEPHRON EPITHELIUM DEVELOPMENT |
5 |
93 |
2.134e-05 |
0.0006755 |
148 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
7 |
236 |
2.237e-05 |
0.0006939 |
149 |
NEGATIVE REGULATION OF GROWTH |
7 |
236 |
2.237e-05 |
0.0006939 |
150 |
EYE DEVELOPMENT |
8 |
326 |
2.211e-05 |
0.0006939 |
151 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
18 |
1710 |
2.563e-05 |
0.0007897 |
152 |
GLAND MORPHOGENESIS |
5 |
97 |
2.617e-05 |
0.000799 |
153 |
REGULATION OF ORGAN MORPHOGENESIS |
7 |
242 |
2.627e-05 |
0.000799 |
154 |
ANTERIOR POSTERIOR AXIS SPECIFICATION |
4 |
48 |
2.665e-05 |
8e-04 |
155 |
POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
4 |
48 |
2.665e-05 |
8e-04 |
156 |
EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
5 |
99 |
2.888e-05 |
0.0008505 |
157 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
5 |
99 |
2.888e-05 |
0.0008505 |
158 |
REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
5 |
99 |
2.888e-05 |
0.0008505 |
159 |
OSSIFICATION |
7 |
251 |
3.317e-05 |
0.00097 |
160 |
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
5 |
102 |
3.335e-05 |
0.00097 |
161 |
ARTERY MORPHOGENESIS |
4 |
51 |
3.395e-05 |
0.0009811 |
162 |
OSTEOBLAST DEVELOPMENT |
3 |
18 |
3.511e-05 |
0.001002 |
163 |
SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION |
3 |
18 |
3.511e-05 |
0.001002 |
164 |
POSITIVE REGULATION OF PROTEIN IMPORT |
5 |
104 |
3.662e-05 |
0.001039 |
165 |
ODONTOGENESIS |
5 |
105 |
3.835e-05 |
0.001081 |
166 |
MESONEPHRIC TUBULE MORPHOGENESIS |
4 |
53 |
3.956e-05 |
0.001105 |
167 |
HOMEOSTASIS OF NUMBER OF CELLS |
6 |
175 |
3.989e-05 |
0.001105 |
168 |
CARDIAC VENTRICLE DEVELOPMENT |
5 |
106 |
4.013e-05 |
0.001105 |
169 |
REGULATION OF CELL DEVELOPMENT |
12 |
836 |
4.01e-05 |
0.001105 |
170 |
FOREBRAIN DEVELOPMENT |
8 |
357 |
4.217e-05 |
0.001154 |
171 |
REGULATION OF OSSIFICATION |
6 |
178 |
4.387e-05 |
0.001194 |
172 |
REGULATION OF KIDNEY DEVELOPMENT |
4 |
55 |
4.583e-05 |
0.00124 |
173 |
RESPONSE TO ALCOHOL |
8 |
362 |
4.652e-05 |
0.001251 |
174 |
FORMATION OF PRIMARY GERM LAYER |
5 |
110 |
4.793e-05 |
0.001282 |
175 |
EMBRYONIC HEMOPOIESIS |
3 |
20 |
4.88e-05 |
0.001298 |
176 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
5 |
112 |
5.225e-05 |
0.001381 |
177 |
REGULATION OF CELL DEATH |
16 |
1472 |
5.447e-05 |
0.001432 |
178 |
REGULATION OF EMBRYONIC DEVELOPMENT |
5 |
114 |
5.685e-05 |
0.001486 |
179 |
MUSCLE TISSUE DEVELOPMENT |
7 |
275 |
5.915e-05 |
0.001532 |
180 |
NEPHRON DEVELOPMENT |
5 |
115 |
5.927e-05 |
0.001532 |
181 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
13 |
1021 |
6.349e-05 |
0.001632 |
182 |
STEM CELL PROLIFERATION |
4 |
60 |
6.464e-05 |
0.001644 |
183 |
POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
4 |
60 |
6.464e-05 |
0.001644 |
184 |
POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT |
3 |
22 |
6.559e-05 |
0.001659 |
185 |
CONNECTIVE TISSUE DEVELOPMENT |
6 |
194 |
7.078e-05 |
0.00178 |
186 |
RESPONSE TO LIPID |
12 |
888 |
7.171e-05 |
0.001794 |
187 |
POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
5 |
121 |
7.55e-05 |
0.001879 |
188 |
RESPIRATORY SYSTEM DEVELOPMENT |
6 |
197 |
7.704e-05 |
0.001907 |
189 |
REGULATION OF CELL GROWTH |
8 |
391 |
7.979e-05 |
0.001964 |
190 |
INOSITOL LIPID MEDIATED SIGNALING |
5 |
124 |
8.48e-05 |
0.002077 |
191 |
POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY |
3 |
24 |
8.576e-05 |
0.002089 |
192 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
9 |
513 |
9.079e-05 |
0.0022 |
193 |
OSTEOBLAST DIFFERENTIATION |
5 |
126 |
9.148e-05 |
0.002205 |
194 |
SOMATIC STEM CELL POPULATION MAINTENANCE |
4 |
66 |
9.4e-05 |
0.002232 |
195 |
FOREBRAIN GENERATION OF NEURONS |
4 |
66 |
9.4e-05 |
0.002232 |
196 |
MESODERM MORPHOGENESIS |
4 |
66 |
9.4e-05 |
0.002232 |
197 |
FOREBRAIN REGIONALIZATION |
3 |
25 |
9.72e-05 |
0.002261 |
198 |
NEURON PROJECTION GUIDANCE |
6 |
205 |
9.593e-05 |
0.002261 |
199 |
THYROID GLAND DEVELOPMENT |
3 |
25 |
9.72e-05 |
0.002261 |
200 |
PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
3 |
25 |
9.72e-05 |
0.002261 |
201 |
NEGATIVE REGULATION OF HEMOPOIESIS |
5 |
128 |
9.855e-05 |
0.002281 |
202 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
5 |
129 |
0.0001022 |
0.002355 |
203 |
REGULATION OF MESONEPHROS DEVELOPMENT |
3 |
26 |
0.0001096 |
0.002488 |
204 |
REGULATION OF T CELL DIFFERENTIATION IN THYMUS |
3 |
26 |
0.0001096 |
0.002488 |
205 |
REGULATION OF THYMOCYTE AGGREGATION |
3 |
26 |
0.0001096 |
0.002488 |
206 |
REGULATION OF LYMPHOCYTE DIFFERENTIATION |
5 |
132 |
0.0001139 |
0.002561 |
207 |
MAINTENANCE OF CELL NUMBER |
5 |
132 |
0.0001139 |
0.002561 |
208 |
POSITIVE REGULATION OF TRANSPORT |
12 |
936 |
0.0001181 |
0.002643 |
209 |
REGULATION OF MAPK CASCADE |
10 |
660 |
0.0001212 |
0.002699 |
210 |
REGULATION OF CATENIN IMPORT INTO NUCLEUS |
3 |
27 |
0.000123 |
0.002725 |
211 |
REGULATION OF WNT SIGNALING PATHWAY |
7 |
310 |
0.0001249 |
0.002744 |
212 |
ENDODERM DEVELOPMENT |
4 |
71 |
0.000125 |
0.002744 |
213 |
PROTEIN PHOSPHORYLATION |
12 |
944 |
0.000128 |
0.002796 |
214 |
RESPONSE TO GONADOTROPIN |
3 |
28 |
0.0001374 |
0.002987 |
215 |
CARDIAC MUSCLE TISSUE DEVELOPMENT |
5 |
140 |
0.0001502 |
0.003251 |
216 |
LOCOMOTION |
13 |
1114 |
0.0001525 |
0.003286 |
217 |
ODONTOGENESIS OF DENTIN CONTAINING TOOTH |
4 |
75 |
0.0001547 |
0.003317 |
218 |
MUSCLE STRUCTURE DEVELOPMENT |
8 |
432 |
0.0001587 |
0.003387 |
219 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
17 |
1791 |
0.0001631 |
0.003466 |
220 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
16 |
1618 |
0.0001658 |
0.003507 |
221 |
DIENCEPHALON DEVELOPMENT |
4 |
77 |
0.0001713 |
0.003591 |
222 |
REGULATION OF BMP SIGNALING PATHWAY |
4 |
77 |
0.0001713 |
0.003591 |
223 |
HORMONE TRANSPORT |
4 |
78 |
0.0001801 |
0.003741 |
224 |
SOMITE DEVELOPMENT |
4 |
78 |
0.0001801 |
0.003741 |
225 |
RESPONSE TO ESTRADIOL |
5 |
146 |
0.0001828 |
0.003766 |
226 |
RESPONSE TO WOUNDING |
9 |
563 |
0.0001829 |
0.003766 |
227 |
CELL MOTILITY |
11 |
835 |
0.0001852 |
0.00378 |
228 |
LOCALIZATION OF CELL |
11 |
835 |
0.0001852 |
0.00378 |
229 |
REGULATION OF LEUKOCYTE DIFFERENTIATION |
6 |
232 |
0.0001884 |
0.003828 |
230 |
ENDOCARDIAL CUSHION DEVELOPMENT |
3 |
32 |
0.0002059 |
0.004129 |
231 |
EMBRYONIC FORELIMB MORPHOGENESIS |
3 |
32 |
0.0002059 |
0.004129 |
232 |
NEGATIVE REGULATION OF T CELL DIFFERENTIATION |
3 |
32 |
0.0002059 |
0.004129 |
233 |
METANEPHROS DEVELOPMENT |
4 |
81 |
0.0002083 |
0.004143 |
234 |
POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION |
4 |
81 |
0.0002083 |
0.004143 |
235 |
HEAD DEVELOPMENT |
10 |
709 |
0.0002167 |
0.004291 |
236 |
EMBRYONIC AXIS SPECIFICATION |
3 |
33 |
0.0002259 |
0.004453 |
237 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
5 |
154 |
0.0002342 |
0.004599 |
238 |
LUNG EPITHELIUM DEVELOPMENT |
3 |
34 |
0.0002471 |
0.004831 |
239 |
NEGATIVE REGULATION OF CELL DEATH |
11 |
872 |
0.0002693 |
0.00522 |
240 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
11 |
872 |
0.0002693 |
0.00522 |
241 |
POSITIVE REGULATION OF MAPK CASCADE |
8 |
470 |
0.000281 |
0.005402 |
242 |
WOUND HEALING |
8 |
470 |
0.000281 |
0.005402 |
243 |
EPIDERMIS DEVELOPMENT |
6 |
253 |
0.0003003 |
0.005726 |
244 |
EPITHELIAL CELL PROLIFERATION |
4 |
89 |
0.0002992 |
0.005726 |
245 |
POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
7 |
360 |
0.0003117 |
0.00592 |
246 |
CORONARY VASCULATURE DEVELOPMENT |
3 |
37 |
0.0003184 |
0.006022 |
247 |
DORSAL VENTRAL PATTERN FORMATION |
4 |
91 |
0.0003258 |
0.006137 |
248 |
POSITIVE REGULATION OF KINASE ACTIVITY |
8 |
482 |
0.0003327 |
0.006155 |
249 |
POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
6 |
258 |
0.0003333 |
0.006155 |
250 |
RESPONSE TO HORMONE |
11 |
893 |
0.00033 |
0.006155 |
251 |
BLOOD VESSEL MORPHOGENESIS |
7 |
364 |
0.0003332 |
0.006155 |
252 |
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
5 |
166 |
0.0003313 |
0.006155 |
253 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
7 |
365 |
0.0003387 |
0.006229 |
254 |
POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
3 |
38 |
0.0003447 |
0.006291 |
255 |
MESENCHYME MORPHOGENESIS |
3 |
38 |
0.0003447 |
0.006291 |
256 |
EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS |
4 |
93 |
0.0003539 |
0.006433 |
257 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
7 |
368 |
0.0003558 |
0.006442 |
258 |
NEGATIVE REGULATION OF CELL GROWTH |
5 |
170 |
0.0003696 |
0.006641 |
259 |
ERBB2 SIGNALING PATHWAY |
3 |
39 |
0.0003725 |
0.006641 |
260 |
ANATOMICAL STRUCTURE MATURATION |
3 |
39 |
0.0003725 |
0.006641 |
261 |
TRABECULA MORPHOGENESIS |
3 |
39 |
0.0003725 |
0.006641 |
262 |
CANONICAL WNT SIGNALING PATHWAY |
4 |
95 |
0.0003838 |
0.006817 |
263 |
MYELOID LEUKOCYTE DIFFERENTIATION |
4 |
96 |
0.0003995 |
0.00704 |
264 |
CARDIOCYTE DIFFERENTIATION |
4 |
96 |
0.0003995 |
0.00704 |
265 |
FORELIMB MORPHOGENESIS |
3 |
40 |
0.0004017 |
0.007053 |
266 |
CELL CELL SIGNALING |
10 |
767 |
0.000405 |
0.007084 |
267 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
8 |
498 |
0.0004135 |
0.007206 |
268 |
AORTA DEVELOPMENT |
3 |
41 |
0.0004323 |
0.007505 |
269 |
LIPID PHOSPHORYLATION |
4 |
99 |
0.000449 |
0.007766 |
270 |
REGULATION OF PROTEIN IMPORT |
5 |
183 |
0.0005175 |
0.008918 |
271 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
4 |
103 |
0.0005217 |
0.008924 |
272 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
4 |
103 |
0.0005217 |
0.008924 |
273 |
BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS |
3 |
44 |
0.0005329 |
0.009083 |
274 |
REGULATION OF BINDING |
6 |
283 |
0.0005439 |
0.009237 |
275 |
PEPTIDYL TYROSINE MODIFICATION |
5 |
186 |
0.0005571 |
0.009427 |
276 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
13 |
1275 |
0.0005634 |
0.009498 |
277 |
LUNG MORPHOGENESIS |
3 |
45 |
0.0005695 |
0.009532 |
278 |
VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT |
3 |
45 |
0.0005695 |
0.009532 |
279 |
REGULATION OF FAT CELL DIFFERENTIATION |
4 |
106 |
0.0005814 |
0.009696 |
280 |
NEURON PROJECTION MORPHOGENESIS |
7 |
402 |
0.0006026 |
0.009978 |
281 |
REGULATION OF T CELL DIFFERENTIATION |
4 |
107 |
0.0006024 |
0.009978 |
282 |
APOPTOTIC SIGNALING PATHWAY |
6 |
289 |
0.0006072 |
0.009991 |
283 |
REGULATION OF ALPHA BETA T CELL DIFFERENTIATION |
3 |
46 |
0.0006077 |
0.009991 |